Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease.

Chiu WH, Carlsson T, Depboylu C, Höglinger GU, Oertel WH, Ries V.

Neuropharmacology. 2014 Apr;79:212-21. doi: 10.1016/j.neuropharm.2013.11.014. Epub 2013 Nov 28.

PMID:
24291466
[PubMed - indexed for MEDLINE]
2.
3.

Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb.

Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J.

Exp Neurol. 2006 Jan;197(1):113-21. Epub 2005 Oct 24.

PMID:
16246330
[PubMed - indexed for MEDLINE]
4.

Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Malmlöf T, Feltmann K, Konradsson-Geuken A, Schneider F, Alken RG, Svensson TH, Schilström B.

J Neural Transm. 2014 Jun 7. [Epub ahead of print]

PMID:
24906468
[PubMed - as supplied by publisher]
5.

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA.

Neurobiol Dis. 2011 Jun;42(3):327-40. doi: 10.1016/j.nbd.2011.01.024. Epub 2011 Feb 19.

PMID:
21310234
[PubMed - indexed for MEDLINE]
6.

Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model.

Winner B, Desplats P, Hagl C, Klucken J, Aigner R, Ploetz S, Laemke J, Karl A, Aigner L, Masliah E, Buerger E, Winkler J.

Exp Neurol. 2009 Oct;219(2):543-52. doi: 10.1016/j.expneurol.2009.07.013. Epub 2009 Jul 18.

PMID:
19619535
[PubMed - indexed for MEDLINE]
7.

Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease.

Prinz A, Selesnew LM, Liss B, Roeper J, Carlsson T.

Exp Neurol. 2013 Oct;248:236-45. doi: 10.1016/j.expneurol.2013.06.015. Epub 2013 Jun 26.

PMID:
23810738
[PubMed - indexed for MEDLINE]
8.

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.

Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Rönnholm H, Wikström L.

J Neurosci Res. 2008 Feb 1;86(2):326-38.

PMID:
17803225
[PubMed - indexed for MEDLINE]
9.
10.

Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.

Lyytinen J, Kaakkola S, Ahtila S, Tuomainen P, Teräväinen H.

Mov Disord. 1997 Jul;12(4):497-505.

PMID:
9251066
[PubMed - indexed for MEDLINE]
11.

Proliferation, migration and differentiation of neuronal progenitor cells in the adult mouse subventricular zone surgically separated from its olfactory bulb.

Jankovski A, Garcia C, Soriano E, Sotelo C.

Eur J Neurosci. 1998 Dec;10(12):3853-68.

PMID:
9875362
[PubMed - indexed for MEDLINE]
12.

Adult neurogenesis restores dopaminergic neuronal loss in the olfactory bulb.

Lazarini F, Gabellec MM, Moigneu C, de Chaumont F, Olivo-Marin JC, Lledo PM.

J Neurosci. 2014 Oct 22;34(43):14430-42. doi: 10.1523/JNEUROSCI.5366-13.2014.

PMID:
25339754
[PubMed - in process]
13.

Nitric oxide is a physiological inhibitor of neurogenesis in the adult mouse subventricular zone and olfactory bulb.

Moreno-López B, Romero-Grimaldi C, Noval JA, Murillo-Carretero M, Matarredona ER, Estrada C.

J Neurosci. 2004 Jan 7;24(1):85-95.

PMID:
14715941
[PubMed - indexed for MEDLINE]
Free Article
14.

Chronic treatment with levodopa and/or selegiline does not affect behavioral recovery induced by fetal ventral mesencephalic grafts in unilaterally 6-hydroxydopamine-lesioned rats.

Adams CE, Hoffman AF, Hudson JL, Hoffer BJ, Boyson SJ.

Exp Neurol. 1994 Dec;130(2):261-8.

PMID:
7867755
[PubMed - indexed for MEDLINE]
15.

Reduced proliferation in the adult mouse subventricular zone increases survival of olfactory bulb interneurons.

Sui Y, Horne MK, Stanić D.

PLoS One. 2012;7(2):e31549. doi: 10.1371/journal.pone.0031549. Epub 2012 Feb 21.

PMID:
22363671
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.

Ravenscroft P, Chalon S, Brotchie JM, Crossman AR.

Exp Neurol. 2004 Jan;185(1):36-46.

PMID:
14697317
[PubMed - indexed for MEDLINE]
18.

Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Shin KS, Choi HS, Zhao TT, Suh KH, Kwon IH, Choi SO, Lee MK.

Arch Pharm Res. 2013 Jun;36(6):759-67. doi: 10.1007/s12272-013-0051-4. Epub 2013 Mar 29.

PMID:
23539311
[PubMed - indexed for MEDLINE]
19.

Entacapone and selegiline with L-dopa in patients with Parkinson's disease: an interaction study.

Lyytinen J, Kaakkola S, Gordin A, Kultalahti E, Teräväinen H.

Parkinsonism Relat Disord. 2000 Oct 1;6(4):215-222.

PMID:
10900396
[PubMed - as supplied by publisher]
20.

Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.

Petit GH, Berkovich E, Hickery M, Kallunki P, Fog K, Fitzer-Attas C, Brundin P.

PLoS One. 2013;8(4):e60691. doi: 10.1371/journal.pone.0060691. Epub 2013 Apr 3.

PMID:
23573275
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk